
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight Loss
Bryn M. Owen, Xunshan Ding, Donald A. Morgan, et al.
Cell Metabolism (2014) Vol. 20, Iss. 4, pp. 670-677
Open Access | Times Cited: 461
Bryn M. Owen, Xunshan Ding, Donald A. Morgan, et al.
Cell Metabolism (2014) Vol. 20, Iss. 4, pp. 670-677
Open Access | Times Cited: 461
Showing 1-25 of 461 citing articles:
Understanding the Physiology of FGF21
Ffolliott M. Fisher, Eleftheria Maratos–Flier
Annual Review of Physiology (2015) Vol. 78, Iss. 1, pp. 223-241
Open Access | Times Cited: 750
Ffolliott M. Fisher, Eleftheria Maratos–Flier
Annual Review of Physiology (2015) Vol. 78, Iss. 1, pp. 223-241
Open Access | Times Cited: 750
Targeting adipose tissue in the treatment of obesity-associated diabetes
Christine M. Kusminski, Perry E. Bickel, Philipp E. Scherer
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 9, pp. 639-660
Closed Access | Times Cited: 619
Christine M. Kusminski, Perry E. Bickel, Philipp E. Scherer
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 9, pp. 639-660
Closed Access | Times Cited: 619
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
Varman T. Samuel, Gerald I. Shulman
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 22-41
Open Access | Times Cited: 611
Varman T. Samuel, Gerald I. Shulman
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 22-41
Open Access | Times Cited: 611
FGF/FGFR signaling in health and disease
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 600
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 600
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
Leiluo Geng, Karen S.L. Lam, Aimin Xu
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 11, pp. 654-667
Closed Access | Times Cited: 451
Leiluo Geng, Karen S.L. Lam, Aimin Xu
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 11, pp. 654-667
Closed Access | Times Cited: 451
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
Saswata Talukdar, Yingjiang Zhou, Dongmei Li, et al.
Cell Metabolism (2016) Vol. 23, Iss. 3, pp. 427-440
Open Access | Times Cited: 443
Saswata Talukdar, Yingjiang Zhou, Dongmei Li, et al.
Cell Metabolism (2016) Vol. 23, Iss. 3, pp. 427-440
Open Access | Times Cited: 443
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Chiara Degirolamo, Carlo Sabbà, Antonio Moschetta
Nature Reviews Drug Discovery (2015) Vol. 15, Iss. 1, pp. 51-69
Closed Access | Times Cited: 383
Chiara Degirolamo, Carlo Sabbà, Antonio Moschetta
Nature Reviews Drug Discovery (2015) Vol. 15, Iss. 1, pp. 51-69
Closed Access | Times Cited: 383
FGF21 Regulates Sweet and Alcohol Preference
Saswata Talukdar, Bryn M. Owen, Parkyong Song, et al.
Cell Metabolism (2015) Vol. 23, Iss. 2, pp. 344-349
Open Access | Times Cited: 294
Saswata Talukdar, Bryn M. Owen, Parkyong Song, et al.
Cell Metabolism (2015) Vol. 23, Iss. 2, pp. 344-349
Open Access | Times Cited: 294
Restoration of metabolic health by decreased consumption of branched‐chain amino acids
Nicole E. Cummings, Elizabeth M. Williams, Ildikó Kasza, et al.
The Journal of Physiology (2017) Vol. 596, Iss. 4, pp. 623-645
Open Access | Times Cited: 280
Nicole E. Cummings, Elizabeth M. Williams, Ildikó Kasza, et al.
The Journal of Physiology (2017) Vol. 596, Iss. 4, pp. 623-645
Open Access | Times Cited: 280
Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
Bryn M. Owen, David J. Mangelsdorf, Steven A. Kliewer
Trends in Endocrinology and Metabolism (2014) Vol. 26, Iss. 1, pp. 22-29
Open Access | Times Cited: 271
Bryn M. Owen, David J. Mangelsdorf, Steven A. Kliewer
Trends in Endocrinology and Metabolism (2014) Vol. 26, Iss. 1, pp. 22-29
Open Access | Times Cited: 271
FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms
Lucas D. BonDurant, Magdalene Ameka, Meghan C. Naber, et al.
Cell Metabolism (2017) Vol. 25, Iss. 4, pp. 935-944.e4
Open Access | Times Cited: 268
Lucas D. BonDurant, Magdalene Ameka, Meghan C. Naber, et al.
Cell Metabolism (2017) Vol. 25, Iss. 4, pp. 935-944.e4
Open Access | Times Cited: 268
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Jan‐Bernd Funcke, Philipp E. Scherer
Journal of Lipid Research (2019) Vol. 60, Iss. 10, pp. 1648-1697
Open Access | Times Cited: 263
Jan‐Bernd Funcke, Philipp E. Scherer
Journal of Lipid Research (2019) Vol. 60, Iss. 10, pp. 1648-1697
Open Access | Times Cited: 263
FGF21 gene therapy as treatment for obesity and insulin resistance
Verónica Jiménez, Claudia Jambrina, Estefanía Casana, et al.
EMBO Molecular Medicine (2018) Vol. 10, Iss. 8
Open Access | Times Cited: 254
Verónica Jiménez, Claudia Jambrina, Estefanía Casana, et al.
EMBO Molecular Medicine (2018) Vol. 10, Iss. 8
Open Access | Times Cited: 254
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
Harald Staiger, Michaela Keuper, Lucia Berti, et al.
Endocrine Reviews (2017) Vol. 38, Iss. 5, pp. 468-488
Open Access | Times Cited: 234
Harald Staiger, Michaela Keuper, Lucia Berti, et al.
Endocrine Reviews (2017) Vol. 38, Iss. 5, pp. 468-488
Open Access | Times Cited: 234
KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference
Günter Schumann, Chunyu Liu, Paul F. O’Reilly, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 50, pp. 14372-14377
Open Access | Times Cited: 230
Günter Schumann, Chunyu Liu, Paul F. O’Reilly, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 50, pp. 14372-14377
Open Access | Times Cited: 230
FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues
Christian Schlein, Saswata Talukdar, Markus Heine, et al.
Cell Metabolism (2016) Vol. 23, Iss. 3, pp. 441-453
Open Access | Times Cited: 229
Christian Schlein, Saswata Talukdar, Markus Heine, et al.
Cell Metabolism (2016) Vol. 23, Iss. 3, pp. 441-453
Open Access | Times Cited: 229
Neural Control of Energy Balance: Translating Circuits to Therapies
Laurent Gautron, Joel K. Elmquist, Kevin W. Williams
Cell (2015) Vol. 161, Iss. 1, pp. 133-145
Open Access | Times Cited: 226
Laurent Gautron, Joel K. Elmquist, Kevin W. Williams
Cell (2015) Vol. 161, Iss. 1, pp. 133-145
Open Access | Times Cited: 226
Endocrine Crosstalk Between Skeletal Muscle and the Brain
Julien Delezie, Christoph Handschin
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 220
Julien Delezie, Christoph Handschin
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 220
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21
Steven A. Kliewer, David J. Mangelsdorf
Cell Metabolism (2019) Vol. 29, Iss. 2, pp. 246-253
Open Access | Times Cited: 220
Steven A. Kliewer, David J. Mangelsdorf
Cell Metabolism (2019) Vol. 29, Iss. 2, pp. 246-253
Open Access | Times Cited: 220
Inter-organ cross-talk in metabolic syndrome
Christina Priest, Peter Tontonoz
Nature Metabolism (2019) Vol. 1, Iss. 12, pp. 1177-1188
Closed Access | Times Cited: 220
Christina Priest, Peter Tontonoz
Nature Metabolism (2019) Vol. 1, Iss. 12, pp. 1177-1188
Closed Access | Times Cited: 220
FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia
Tian Lan, Donald A. Morgan, Kamal Rahmouni, et al.
Cell Metabolism (2017) Vol. 26, Iss. 5, pp. 709-718.e3
Open Access | Times Cited: 219
Tian Lan, Donald A. Morgan, Kamal Rahmouni, et al.
Cell Metabolism (2017) Vol. 26, Iss. 5, pp. 709-718.e3
Open Access | Times Cited: 219
Skeletal muscle mitochondrial remodeling in exercise and diseases
Zhenji Gan, Tingting Fu, Daniel P. Kelly, et al.
Cell Research (2018) Vol. 28, Iss. 10, pp. 969-980
Open Access | Times Cited: 215
Zhenji Gan, Tingting Fu, Daniel P. Kelly, et al.
Cell Research (2018) Vol. 28, Iss. 10, pp. 969-980
Open Access | Times Cited: 215
The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review
Adrian M. González-Gil, Leticia Elizondo‐Montemayor
Nutrients (2020) Vol. 12, Iss. 6, pp. 1899-1899
Open Access | Times Cited: 213
Adrian M. González-Gil, Leticia Elizondo‐Montemayor
Nutrients (2020) Vol. 12, Iss. 6, pp. 1899-1899
Open Access | Times Cited: 213
Metabolic Messengers: FGF21
Kyle H. Flippo, Matthew J. Potthoff
Nature Metabolism (2021) Vol. 3, Iss. 3, pp. 309-317
Open Access | Times Cited: 206
Kyle H. Flippo, Matthew J. Potthoff
Nature Metabolism (2021) Vol. 3, Iss. 3, pp. 309-317
Open Access | Times Cited: 206
Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice
Nicholas Douris, Darko Stevanović, Ffolliott M. Fisher, et al.
Endocrinology (2015) Vol. 156, Iss. 7, pp. 2470-2481
Open Access | Times Cited: 196
Nicholas Douris, Darko Stevanović, Ffolliott M. Fisher, et al.
Endocrinology (2015) Vol. 156, Iss. 7, pp. 2470-2481
Open Access | Times Cited: 196